Identifying the culprit lesion in tumor induced hypophosphatemia, the solution of a clinical enigma

Tumor-induced osteomalacia is a rare acquired metabolic bone disorder characterized by isolated renal phosphate wasting due to abnormal tumor production of fibroblast growth factor 23. We report the case of a 59 year old woman referred to our department with a long history of progressive diffuse mus...

Descripción completa

Detalles Bibliográficos
Autores principales: Slot-Steenks, Mathilde M. Bruins, Hamdy, Neveen A.T., van de Sande, Michiel A.J., Vriens, Dennis, Cleven, Arjen H.G., Appelman-Dijkstra, Natasha M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Clinical Management of Endocrine Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5107201/
https://www.ncbi.nlm.nih.gov/pubmed/27709474
http://dx.doi.org/10.1007/s12020-016-1092-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5107201/
https://www.ncbi.nlm.nih.gov/pubmed/27709474
http://dx.doi.org/10.1007/s12020-016-1092-5

Ejemplares similares